Floatz logo

Desmopressin

Nocturnal Enuresis

Montefiore Medical Centerprotein_peptidePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Nocturnal Enuresis cohort.

Asset / SponsorPhaseRating
Valproic Acid
Mansoura University Hospital
UnknownD

Same molecule, other indications

Desmopressin is also rated in:

hemophilia AActive
BB
Indicative · Phase 4
66 / 100
View asset →
sickle cell diseaseDormant
BB
Indicative · Phase 4
65 / 100
View asset →
stroke disorderDormant
BB
Indicative · Phase 2
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →